A Study of the Effectiveness and Safety of JS1-1-01 Tablet in Patients With Moderate to Severe Depression
Clinical trial NCT07485595 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07485595
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-30
- Primary completion
- 2026-12-31
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.